Skip to main content
Top
Published in: Radiation Oncology 1/2023

Open Access 01-12-2023 | Ventricular Tachycardia | Research

Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems

Authors: Ching-Yu Wang, Li-Ting Ho, Lian-Yu Lin, Hsing-Min Chan, Hung-Yi Chen, Tung-Lin Yu, Yu-Sen Huang, Sung-Hsin Kuo, Wen-Jeng Lee, Jenny Ling-Yu Chen

Published in: Radiation Oncology | Issue 1/2023

Login to get access

Abstract

Background

Few dosimetric comparisons have been published between linear accelerator (LA)-based systems and CyberKnife (CK)-based robotic radiosurgery systems for cardiac radio-ablation in ventricular tachycardia. This study aimed to compare the dosimetry of noninvasive cardiac radio-ablation deliverable on LA with that on CK.

Methods

Thirteen patients who underwent noninvasive cardiac radio-ablation by LA were included. The prescribed dose was 25 Gy in 1 fraction, and the average planning target volume was 49.8 ± 31.0 cm3 (range, 14.4–93.7 cm3). CK plans were generated for comparison.

Results

Both the CK and LA plans accomplished appropriate dose coverage and normal tissue sparing. Compared with the LA plans, the CK plans achieved significantly lower gradient indices (3.12 ± 0.71 vs. 3.48 ± 0.55, p = 0.031) and gradient measures (1.00 ± 0.29 cm vs. 1.17 ± 0.29 cm, p < 0.001). They had similar equivalent conformity indices (CK vs. LA: 0.84 ± 0.08 vs. 0.87 ± 0.07, p = 0.093) and maximum doses 2 cm from the planning target volume (PTV) in any direction (CK vs. LA: 50.8 ± 9.9% vs. 53.1 ± 5.3%, p = 0.423). The dosimetric advantages of CK were more prominent in patients with a PTV of ≤ 50 cm3 or a spherical PTV. In patients with a PTV of > 50 cm3 or a non-spherical PTV, the LA and CK plans were similar regarding dosimetric parameters. CK plans involved more beams (232.2 ± 110.8 beams vs. 10.0 ± 1.7 arcs) and longer treatment times (119.2 ± 43.3 min vs. 22.4 ± 1.6 min, p = 0.007).

Conclusions

Both CK and LA are ideal modalities for noninvasive cardiac radio-ablation. Upfront treatment should be considered based on clinical intent.
Literature
1.
go back to reference Siedow M, Brownstein J, Prasad RN, Loccoh E, Harfi TT, Okabe T, Tong MS, Afzal MR, Williams T. Cardiac radioablation in the treatment of ventricular tachycardia. Clin Transl Radiat Oncol. 2021;31:71–9.PubMedPubMedCentral Siedow M, Brownstein J, Prasad RN, Loccoh E, Harfi TT, Okabe T, Tong MS, Afzal MR, Williams T. Cardiac radioablation in the treatment of ventricular tachycardia. Clin Transl Radiat Oncol. 2021;31:71–9.PubMedPubMedCentral
2.
go back to reference Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L, Andratschke N, Mayinger M, Saguner AM, Steffel J, et al. Stereotactic radiotherapy for the management of refractory ventricular tachycardia: promise and future directions. Front Cardiovasc Med. 2020;7:108.CrossRefPubMedPubMedCentral Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L, Andratschke N, Mayinger M, Saguner AM, Steffel J, et al. Stereotactic radiotherapy for the management of refractory ventricular tachycardia: promise and future directions. Front Cardiovasc Med. 2020;7:108.CrossRefPubMedPubMedCentral
3.
go back to reference Qian PC, Quadros K, Aguilar M, Wei C, Boeck M, Bredfeldt J, Cochet H, Blankstein R, Mak R, Sauer WH, et al. Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy. JACC Clin Electrophysiol. 2022;8:49–58.CrossRefPubMed Qian PC, Quadros K, Aguilar M, Wei C, Boeck M, Bredfeldt J, Cochet H, Blankstein R, Mak R, Sauer WH, et al. Substrate modification using stereotactic radioablation to treat refractory ventricular tachycardia in patients with ischemic cardiomyopathy. JACC Clin Electrophysiol. 2022;8:49–58.CrossRefPubMed
4.
go back to reference Lee J, Bates M, Shepherd E, Riley S, Henshaw M, Metherall P, Daniel J, Blower A, Scoones D, Wilkinson M, et al. Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience. Open Heart. 2021;8:e001770.CrossRefPubMedPubMedCentral Lee J, Bates M, Shepherd E, Riley S, Henshaw M, Metherall P, Daniel J, Blower A, Scoones D, Wilkinson M, et al. Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience. Open Heart. 2021;8:e001770.CrossRefPubMedPubMedCentral
5.
go back to reference Ho LT, Chen JL, Chan HM, Huang YC, Su MY, Kuo SH, Chang YC, Lin JL, Chen WJ, Lee WJ, et al. First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias. Sci Rep. 2021;11:10360.CrossRefPubMedPubMedCentral Ho LT, Chen JL, Chan HM, Huang YC, Su MY, Kuo SH, Chang YC, Lin JL, Chen WJ, Lee WJ, et al. First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias. Sci Rep. 2021;11:10360.CrossRefPubMedPubMedCentral
6.
go back to reference Chin R, Hayase J, Hu P, Cao M, Deng J, Ajijola O, Do D, Vaseghi M, Buch E, Khakpour H, et al. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience. J Interv Card Electrophysiol. 2021;61:535–43.CrossRefPubMed Chin R, Hayase J, Hu P, Cao M, Deng J, Ajijola O, Do D, Vaseghi M, Buch E, Khakpour H, et al. Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience. J Interv Card Electrophysiol. 2021;61:535–43.CrossRefPubMed
7.
go back to reference Carbucicchio C, Jereczek-Fossa BA, Andreini D, Catto V, Piperno G, Conte E, Cattani F, Rondi E, Vigorito S, Piccolo C, et al. STRA-MI-VT (stereotactic radioablation by multimodal imaging for ventricular tachycardia): rationale and design of an Italian experimental prospective study. J Interv Card Electrophysiol. 2021;61:583–93.CrossRefPubMed Carbucicchio C, Jereczek-Fossa BA, Andreini D, Catto V, Piperno G, Conte E, Cattani F, Rondi E, Vigorito S, Piccolo C, et al. STRA-MI-VT (stereotactic radioablation by multimodal imaging for ventricular tachycardia): rationale and design of an Italian experimental prospective study. J Interv Card Electrophysiol. 2021;61:583–93.CrossRefPubMed
8.
go back to reference Lloyd MS, Wight J, Schneider F, Hoskins M, Attia T, Escott C, Lerakis S, Higgins KA. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm. 2020;17:415–22.CrossRefPubMed Lloyd MS, Wight J, Schneider F, Hoskins M, Attia T, Escott C, Lerakis S, Higgins KA. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm. 2020;17:415–22.CrossRefPubMed
9.
go back to reference Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S, Goddu SM, Lang A, Cooper DH, Faddis M, et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019;139:313–21.CrossRefPubMedPubMedCentral Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S, Goddu SM, Lang A, Cooper DH, Faddis M, et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019;139:313–21.CrossRefPubMedPubMedCentral
10.
go back to reference Gianni C, Rivera D, Burkhardt JD, Pollard B, Gardner E, Maguire P, Zei PC, Natale A, Al-Ahmad A. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm. 2020;17:1241–8.CrossRefPubMed Gianni C, Rivera D, Burkhardt JD, Pollard B, Gardner E, Maguire P, Zei PC, Natale A, Al-Ahmad A. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm. 2020;17:1241–8.CrossRefPubMed
11.
go back to reference Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M, Fiala M, Peichl P, Feltl D, Januska J, et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace. 2019;21:1088–95.CrossRefPubMed Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M, Fiala M, Peichl P, Feltl D, Januska J, et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace. 2019;21:1088–95.CrossRefPubMed
12.
go back to reference Herrera Siklody C, Pruvot E, Pascale P, Kinj R, Jumeau R, Le Bloa M, Teres C, Domenichini G, Porretta AP, Ozsahin M, et al. Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation. Clin Transl Radiat Oncol. 2022;37:89–93.PubMedPubMedCentral Herrera Siklody C, Pruvot E, Pascale P, Kinj R, Jumeau R, Le Bloa M, Teres C, Domenichini G, Porretta AP, Ozsahin M, et al. Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation. Clin Transl Radiat Oncol. 2022;37:89–93.PubMedPubMedCentral
13.
go back to reference Ninni S, Gallot-Lavallée T, Klein C, Longère B, Brigadeau F, Potelle C, Crop F, Rault E, Decoene C, Lacornerie T, et al. Stereotactic radioablation for ventricular tachycardia in the setting of electrical storm. Circ Arrhythm Electrophysiol. 2022;15:e010955.CrossRefPubMed Ninni S, Gallot-Lavallée T, Klein C, Longère B, Brigadeau F, Potelle C, Crop F, Rault E, Decoene C, Lacornerie T, et al. Stereotactic radioablation for ventricular tachycardia in the setting of electrical storm. Circ Arrhythm Electrophysiol. 2022;15:e010955.CrossRefPubMed
14.
go back to reference Weidlich GA, Hacker F, Bellezza D, Maguire P, Gardner EA. Ventricular tachycardia: a treatment comparison study of the CyberKnife with conventional linear accelerators. Cureus. 2018;10:e3445.PubMedPubMedCentral Weidlich GA, Hacker F, Bellezza D, Maguire P, Gardner EA. Ventricular tachycardia: a treatment comparison study of the CyberKnife with conventional linear accelerators. Cureus. 2018;10:e3445.PubMedPubMedCentral
15.
go back to reference Kluge A, Ehrbar S, Grehn M, Fleckenstein J, Baus WW, Siebert FA, Schweikard A, Andratschke N, Mayinger MC, Boda-Heggemann J, et al. Treatment planning for cardiac radioablation: multicenter multiplatform benchmarking for the radiosurgery for ventricular tachycardia (RAVENTA) trial. Int J Radiat Oncol Biol Phys. 2022;114:360–72.CrossRefPubMed Kluge A, Ehrbar S, Grehn M, Fleckenstein J, Baus WW, Siebert FA, Schweikard A, Andratschke N, Mayinger MC, Boda-Heggemann J, et al. Treatment planning for cardiac radioablation: multicenter multiplatform benchmarking for the radiosurgery for ventricular tachycardia (RAVENTA) trial. Int J Radiat Oncol Biol Phys. 2022;114:360–72.CrossRefPubMed
16.
go back to reference Blanck O, Buergy D, Vens M, Eidinger L, Zaman A, Krug D, Rudic B, Boda-Heggemann J, Giordano FA, Boldt LH, et al. Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA). Clin Res Cardiol. 2020;109:1319–32.CrossRefPubMedPubMedCentral Blanck O, Buergy D, Vens M, Eidinger L, Zaman A, Krug D, Rudic B, Boda-Heggemann J, Giordano FA, Boldt LH, et al. Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA). Clin Res Cardiol. 2020;109:1319–32.CrossRefPubMedPubMedCentral
17.
go back to reference Huang YS, Chen JL, Hsu FM, Huang JY, Ko WC, Chen YC, Jaw FS, Yen RF, Chang YC. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients. J Magn Reson Imaging. 2018;47:191–9.CrossRefPubMed Huang YS, Chen JL, Hsu FM, Huang JY, Ko WC, Chen YC, Jaw FS, Yen RF, Chang YC. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients. J Magn Reson Imaging. 2018;47:191–9.CrossRefPubMed
18.
go back to reference Brownstein J, Afzal M, Okabe T, Harfi TT, Tong MS, Thomas E, Hugo G, Cuculich P, Robinson C, Williams TM. Method and atlas to enable targeting for cardiac radioablation employing the American heart association segmented model. Int J Radiat Oncol Biol Phys. 2021;111:178–85.CrossRefPubMed Brownstein J, Afzal M, Okabe T, Harfi TT, Tong MS, Thomas E, Hugo G, Cuculich P, Robinson C, Williams TM. Method and atlas to enable targeting for cardiac radioablation employing the American heart association segmented model. Int J Radiat Oncol Biol Phys. 2021;111:178–85.CrossRefPubMed
19.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105:539–42.CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105:539–42.CrossRefPubMed
20.
go back to reference Knutson NC, Samson PP, Hugo GD, Goddu SM, Reynoso FJ, Kavanaugh JA, Mutic S, Moore K, Hilliard J, Cuculich PS, et al. Radiation therapy workflow and dosimetric analysis from a phase 1/2 trial of noninvasive cardiac radioablation for ventricular tachycardia. Int J Radiat Oncol Biol Phys. 2019;104:1114–23.CrossRefPubMed Knutson NC, Samson PP, Hugo GD, Goddu SM, Reynoso FJ, Kavanaugh JA, Mutic S, Moore K, Hilliard J, Cuculich PS, et al. Radiation therapy workflow and dosimetric analysis from a phase 1/2 trial of noninvasive cardiac radioablation for ventricular tachycardia. Int J Radiat Oncol Biol Phys. 2019;104:1114–23.CrossRefPubMed
21.
go back to reference Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys. 2010;37:4078–101.CrossRefPubMed Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, et al. Stereotactic body radiation therapy: the report of AAPM task group 101. Med Phys. 2010;37:4078–101.CrossRefPubMed
22.
go back to reference Pepin MD, Penoncello GP, Brom KM, Gustafson JM, Long KM, Rong Y, de Fong Los Santos LE, Shiraishi S. Assessment of dose-volume histogram precision for five clinical systems. Med Phys. 2022;49:6303–18.CrossRefPubMed Pepin MD, Penoncello GP, Brom KM, Gustafson JM, Long KM, Rong Y, de Fong Los Santos LE, Shiraishi S. Assessment of dose-volume histogram precision for five clinical systems. Med Phys. 2022;49:6303–18.CrossRefPubMed
23.
go back to reference Torrens M, Chung C, Chung HT, Hanssens P, Jaffray D, Kemeny A, Larson D, Levivier M, Lindquist C, Lippitz B, et al. Standardization of terminology in stereotactic radiosurgery: report from the standardization committee of the international leksell gamma knife society: special topic. J Neurosurg. 2014;121(Suppl):2–15.CrossRefPubMed Torrens M, Chung C, Chung HT, Hanssens P, Jaffray D, Kemeny A, Larson D, Levivier M, Lindquist C, Lippitz B, et al. Standardization of terminology in stereotactic radiosurgery: report from the standardization committee of the international leksell gamma knife society: special topic. J Neurosurg. 2014;121(Suppl):2–15.CrossRefPubMed
24.
go back to reference Janowski E, Chen LN, Kim JS, Lei S, Suy S, Collins B, Lynch J, Dritschilo A, Collins S. Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥ 50 cm3). Radiat Oncol. 2014;9:241.CrossRefPubMedPubMedCentral Janowski E, Chen LN, Kim JS, Lei S, Suy S, Collins B, Lynch J, Dritschilo A, Collins S. Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥ 50 cm3). Radiat Oncol. 2014;9:241.CrossRefPubMedPubMedCentral
25.
go back to reference Collins SP, Coppa ND, Zhang Y, Collins BT, McRae DA, Jean WC. CyberKnife radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters. Radiat Oncol. 2006;1:46.CrossRefPubMedPubMedCentral Collins SP, Coppa ND, Zhang Y, Collins BT, McRae DA, Jean WC. CyberKnife radiosurgery in the treatment of complex skull base tumors: analysis of treatment planning parameters. Radiat Oncol. 2006;1:46.CrossRefPubMedPubMedCentral
26.
go back to reference Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, Kaheng Chan M, Ernst I, Krieger T, Duma M-N, Oechsner M, Ganswindt U, Heinz C, et al. Planning benchmark study for SBRT of early stage NSCLC. Strahlenther Onkol. 2017;193:780–90.CrossRefPubMed Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, Kaheng Chan M, Ernst I, Krieger T, Duma M-N, Oechsner M, Ganswindt U, Heinz C, et al. Planning benchmark study for SBRT of early stage NSCLC. Strahlenther Onkol. 2017;193:780–90.CrossRefPubMed
27.
go back to reference Villaggi E, Hernandez V, Fusella M, Moretti E, Russo S, Vaccara EML, Nardiello B, Esposito M, Saez J, Cilla S, et al. Plan quality improvement by DVH sharing and planner’s experience: Results of a SBRT multicentric planning study on prostate. Phys Med. 2019;62:73–82.CrossRefPubMed Villaggi E, Hernandez V, Fusella M, Moretti E, Russo S, Vaccara EML, Nardiello B, Esposito M, Saez J, Cilla S, et al. Plan quality improvement by DVH sharing and planner’s experience: Results of a SBRT multicentric planning study on prostate. Phys Med. 2019;62:73–82.CrossRefPubMed
28.
go back to reference Petrovic B, Grządziel A, Ślosarek K. Quality assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iPlan RT dose. Rep Pract Oncol Radiother. 2009;14:5–10.CrossRef Petrovic B, Grządziel A, Ślosarek K. Quality assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iPlan RT dose. Rep Pract Oncol Radiother. 2009;14:5–10.CrossRef
29.
go back to reference Akino Y, Das IJ, Cardenes HR, Desrosiers CM. Correlation between target volume and electron transport effects affecting heterogeneity corrections in stereotactic body radiotherapy for lung cancer. J Radiat Res. 2014;55:754–60.CrossRefPubMedPubMedCentral Akino Y, Das IJ, Cardenes HR, Desrosiers CM. Correlation between target volume and electron transport effects affecting heterogeneity corrections in stereotactic body radiotherapy for lung cancer. J Radiat Res. 2014;55:754–60.CrossRefPubMedPubMedCentral
30.
go back to reference Blamek S, Grządziel A, Miszczyk L. Robotic radiosurgery versus micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations. Radiat Oncol. 2013;8:205.CrossRefPubMedPubMedCentral Blamek S, Grządziel A, Miszczyk L. Robotic radiosurgery versus micro-multileaf collimator: a dosimetric comparison for large or critically located arteriovenous malformations. Radiat Oncol. 2013;8:205.CrossRefPubMedPubMedCentral
31.
go back to reference Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004;59:242–9.CrossRefPubMed Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys. 2004;59:242–9.CrossRefPubMed
32.
go back to reference Jang SY, Lalonde R, Ozhasoglu C, Burton S, Heron D, Huq MS. Dosimetric comparison between cone/Iris-based and InCise MLC-based CyberKnife plans for single and multiple brain metastases. J Appl Clin Med Phys. 2016;17:184–99.CrossRefPubMedPubMedCentral Jang SY, Lalonde R, Ozhasoglu C, Burton S, Heron D, Huq MS. Dosimetric comparison between cone/Iris-based and InCise MLC-based CyberKnife plans for single and multiple brain metastases. J Appl Clin Med Phys. 2016;17:184–99.CrossRefPubMedPubMedCentral
Metadata
Title
Noninvasive cardiac radioablation for ventricular tachycardia: dosimetric comparison between linear accelerator- and robotic CyberKnife-based radiosurgery systems
Authors
Ching-Yu Wang
Li-Ting Ho
Lian-Yu Lin
Hsing-Min Chan
Hung-Yi Chen
Tung-Lin Yu
Yu-Sen Huang
Sung-Hsin Kuo
Wen-Jeng Lee
Jenny Ling-Yu Chen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2023
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-023-02370-w

Other articles of this Issue 1/2023

Radiation Oncology 1/2023 Go to the issue